SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Zonagen (zona) - good buy? -- Ignore unavailable to you. Want to Upgrade?


To: Tokyo VD who wrote (5961)11/20/1998 3:04:00 PM
From: Dauntless  Read Replies (1) | Respond to of 7041
 
Tokyo - Devil's advocate?

I think you go a good bit beyond that role.

I'm weary of providing proof & answering every picayune question thrown out by certain folks on this thread. Instead of arguing about a bunch of little crap that can't be proven one way or another at this time I'll repeat the important information & wait for you, or another "Devil's advocate" to disprove it.

<<Show me a MAJOR milestone that the company has established that has not been attained? They haven't always been exactly on time, but what emerging biotech/pharma has been?? Over the last 18 months, while essentially keeping their mouths shut, Zonagen has destroyed, one by one, every claim (read: LIES) of the shorts - every one of them.>>

Here's a recap of naysayings & eventual facts

Zonagen will NEVER get a marketing partner - they did
Zonagen will NEVER get a patent for Vasomax - they did
Zonagen will NEVER get a patent for Chitosan - they did
Zonagen will NEVER file their NDA - they did
Zonagen will NEVER buy back a single share of their stock - they did
Zonagen will NEVER have appreciable sales in Mexico - they did
Zonagen will NEVER get their NDA accepted - they did

One last prediction
Zonagen will NEVER succeed as a one product company - just watch!!!

There's one thing we agree upon ....

Tick tock